Skip to main content
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Subscribe
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
November 2015 Vol 8, No 8
Editorial
My Kind of Town
David B. Nash, MD, MBA
Read More
Business
Characteristics of Academic Detailing: Results of a Literature Review
Thomas J. Van Hoof, MD, EdD
,
Lisa G. Harrison, MSN
,
Nicole E. Miller, BS
,
Maryanne S. Pappas, MS
,
Michael A. Fischer, MD, MS
Read More
Clinical
Reviewing the Unmet Needs of Patients with Multiple Sclerosis
Stanton R. Mehr
,
Marj P. Zimmerman, BSPharm, MS
Read More
Clinical
How Do PCSK9 Inhibitors Stack Up to Statins for Low-Density Lipoprotein Cholesterol Control?
Marj P. Zimmerman, BSPharm, MS
Read More
Clinical
The Latest Innovations in the Drug Pipeline for Multiple Sclerosis
Lea Radick
,
Stanton R. Mehr
Read More
Results 1 - 5 of 5